Bridge Creek Capital Management LLC increased its position in Henry Schein, Inc. (NASDAQ:HSIC) by 1.5% in the third quarter, according to its most recent 13F filing with the SEC. The firm owned 39,904 shares of the company’s stock after purchasing an additional 582 shares during the period. Bridge Creek Capital Management LLC’s holdings in Henry Schein were worth $2,534,000 at the end of the most recent reporting period.

Other institutional investors have also recently bought and sold shares of the company. Vanguard Group Inc. lifted its position in Henry Schein by 2.4% in the 2nd quarter. Vanguard Group Inc. now owns 16,865,641 shares of the company’s stock worth $1,178,909,000 after buying an additional 391,485 shares in the last quarter. Longview Partners Guernsey LTD lifted its position in Henry Schein by 15.8% in the 2nd quarter. Longview Partners Guernsey LTD now owns 15,527,241 shares of the company’s stock worth $1,085,354,000 after buying an additional 2,117,869 shares in the last quarter. Atlanta Capital Management Co. L L C lifted its position in Henry Schein by 0.5% in the 2nd quarter. Atlanta Capital Management Co. L L C now owns 6,343,280 shares of the company’s stock worth $443,395,000 after buying an additional 30,201 shares in the last quarter. JPMorgan Chase & Co. lifted its position in Henry Schein by 9.8% in the 2nd quarter. JPMorgan Chase & Co. now owns 2,664,995 shares of the company’s stock worth $184,285,000 after buying an additional 238,078 shares in the last quarter. Finally, Northern Trust Corp lifted its position in Henry Schein by 1.1% in the 2nd quarter. Northern Trust Corp now owns 1,959,014 shares of the company’s stock worth $136,934,000 after buying an additional 20,415 shares in the last quarter.

HSIC has been the subject of a number of research analyst reports. TheStreet downgraded shares of Henry Schein from a “b” rating to a “c+” rating in a research report on Friday, August 30th. Zacks Investment Research downgraded shares of Henry Schein from a “buy” rating to a “hold” rating and set a $76.00 price target on the stock. in a report on Wednesday, June 19th. Barrington Research restated a “buy” rating and set a $75.00 price target on shares of Henry Schein in a report on Wednesday, August 7th. BidaskClub downgraded shares of Henry Schein from a “hold” rating to a “sell” rating in a report on Thursday, September 26th. Finally, William Blair downgraded shares of Henry Schein from an “outperform” rating to a “market perform” rating in a report on Wednesday, August 7th. Six analysts have rated the stock with a sell rating, nine have issued a hold rating and four have issued a buy rating to the company. The stock has an average rating of “Hold” and a consensus target price of $74.23.

In related news, Vice Chairman James P. Breslawski sold 6,856 shares of Henry Schein stock in a transaction on Wednesday, August 7th. The shares were sold at an average price of $60.17, for a total value of $412,525.52. Following the transaction, the insider now owns 249,046 shares in the company, valued at approximately $14,985,097.82. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 1.06% of the company’s stock.

Shares of Henry Schein stock traded up $0.25 during midday trading on Thursday, reaching $62.36. 46,132 shares of the company’s stock traded hands, compared to its average volume of 1,035,395. The company has a market cap of $9.21 billion, a price-to-earnings ratio of 15.10, a price-to-earnings-growth ratio of 2.43 and a beta of 0.86. The company’s 50 day simple moving average is $62.15 and its 200 day simple moving average is $64.94. The company has a debt-to-equity ratio of 0.33, a quick ratio of 0.95 and a current ratio of 1.70. Henry Schein, Inc. has a 52 week low of $56.58 and a 52 week high of $72.81.

Henry Schein (NASDAQ:HSIC) last announced its earnings results on Tuesday, August 6th. The company reported $0.84 EPS for the quarter, topping the consensus estimate of $0.83 by $0.01. The firm had revenue of $2.45 billion for the quarter, compared to the consensus estimate of $2.48 billion. Henry Schein had a net margin of 4.18% and a return on equity of 16.67%. The business’s quarterly revenue was up 5.7% on a year-over-year basis. During the same quarter last year, the firm posted $1.04 EPS. As a group, equities research analysts predict that Henry Schein, Inc. will post 3.46 earnings per share for the current year.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

See Also: The Structure of a Futures Contract

Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC).

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.